<DOC>
	<DOC>NCT00473655</DOC>
	<brief_summary>The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and 20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride levels.</brief_summary>
	<brief_title>Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Hyperlipoproteinemias</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type IV</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type V</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients older than 18 years, both genders, without any previous treatment with statins or other lipid lowering drugs for at least 6 months With elevated triglycerides above 200 and below 800mg/dl and willing to follow all study procedures including assisting to clinics, fasting before blood samples and signing a written consent High levels of lowdensity lipoprotein cholesterol (LDLC) Unstable cardiovascular condition or awaiting a myocardial revascularization Congestive cardiac failure Uncontrolled diabetes Cancer Uncontrolled hypothyroidism Familial hypercholesterolemia Liver/muscle disease Pregnancy Other</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Triglycerides</keyword>
	<keyword>hypertriglyceridemia</keyword>
	<keyword>statins</keyword>
	<keyword>rosuvastatin</keyword>
	<keyword>hyperlipoproteinemia</keyword>
	<keyword>Fredrickson Type IIb or IV</keyword>
</DOC>